ready HEP Drug Interactions

General Information
Currently 170 million people worldwide are infected with the hepatitis C virus (HCV) and >300 million with hepatitis B (HBV). Although interferon-free combination direct acting antivirals (DAAs) regimens have improved tolerability and efficacy for HCV-infected patients, drug-drug interactions (DDIs) have the potential to cause harm due to liver dysfunction, multiple comorbidities and comedications. This web site was established in 2010 by members of the Department of Pharmacology at the University of Liverpool to offer a resource for healthcare providers, researchers and patients to be able to understand and manage drug-drug interactions.

Awaiting DOI assignment.

Record added: April 21, 2020, 11:20 a.m.
Record updated: April 21, 2020, 12:53 p.m. by The FAIRsharing Team.

Show edit history

In Collections



Additional Information

Access / Retrieve Data

Conditions of Use

Applies to: Data use

Data Curation

Data Access


No publications available

Related Standards

Reporting Guidelines

No guidelines defined

Terminology Artifacts

No semantic standards defined

Models and Formats

No syntax standards defined

Identifier Schemas

No identifier schema standards defined


No metrics standards defined

Related Databases

No related databases defined

Implementing Policies

This record is not implemented by any policy.


Record Maintainer

  • This record is in need of a maintainer. If you login, you'll be able to claim this record.